Abstract
A phase II study utilizing VP-16 and adriamycin in a randomized fashion tested the concept of synchronization of the drugs in treatment of metastatic breast cancer. Although there was a trend in median survival following the synchronized schedule, there was no significant difference in survival or progression-free intervals. The concept of synchronization was not established.
Original language | English (US) |
---|---|
Pages (from-to) | 149-151 |
Number of pages | 3 |
Journal | Oncology |
Volume | 37 |
Issue number | 3 |
DOIs | |
State | Published - 1980 |
ASJC Scopus subject areas
- Oncology
- Cancer Research